Your browser doesn't support javascript.
loading
Endocrine Dysfunction From Immune Checkpoint Inhibitors: Pearls and Pitfalls in Evaluation and Management.
Kotwal, Anupam; Perlman, Jordan E; Goldner, Whitney S; Marr, Alissa; Mammen, Jennifer S.
Afiliación
  • Kotwal A; Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
  • Perlman JE; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University Medical Center, Baltimore, MD.
  • Goldner WS; Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
  • Marr A; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
  • Mammen JS; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University Medical Center, Baltimore, MD.
JCO Oncol Pract ; 19(7): 395-402, 2023 07.
Article en En | MEDLINE | ID: mdl-37023383
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: JCO Oncol Pract Año: 2023 Tipo del documento: Article País de afiliación: Níger
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: JCO Oncol Pract Año: 2023 Tipo del documento: Article País de afiliación: Níger